The U.S. Food and Drug Administration is warning that exposure to Evamist, a spray used to control hot flashes during menopause, may be associated with early puberty and early breast development in young children. The FDA reports that there were eight children between the ages of three and five who experienced premature puberty, nipple swelling, breast development and breast enlargement after "unintended exposure" to Evamist. According to an FDA spokesperson, "unintended exposure" likely means casual contact, such as hugging.
Food and Drug Administration -
Menopause -
Breast -
Hot flash -
Puberty